SLC19A2 and thiamine-responsive megaloblastic anemia syndrome: The latter is exemplified by the development of diabetes in patients with the autosomal recessive disorder thiamin responsive megaloblastic anemia (TRMA), which is caused by mutations in thiamin transporter -1, the product of the SLC19A2 gene [10], [11].